Dr Leif Schauser
Director of Biomedical Genomics,
Global Product Management
Digital Insights Business Area, QIAGEN Aarhus A/S
Tuesday 24th November 2020 15.30 CET
Workshop: from sample to insight
QIAGENs tag line is “Sample to Insight”, reflecting the historical roots (nucleic acid extraction kits) as well as the more recent history of growth into bringing to the market solutions that provide insight into the “meaning” of the sequence of these nucleic acids in a given sample. Examples are presence of actionable DNA markers in FFPE samples from the clinic, unravelling the immune responses upon SARS-CoV-2 infection through measurements of gene expression or tracing COVID-19 outbreaks.
Vishal Kapoor et al (2018) Using GeneReader NGS system to identify mutations in BRCA 1/2 genes in matched FFPE and blood samples. Journal of Clinical Oncology 36:15_suppl, e17536-e17536
Garvin MR, Alvarez C, Miller JI, et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. Elife. 2020;9:e59177. Published 2020 Jul 7. doi:10.7554/eLife.59177
Richard L Tillett, Joel R Sevinsky et al (2020) Genomic evidence for reinfection with SARS-CoV-2: a case study The Lancet Infectious Diseases, Available online 12 October 2020
Leif Schauser holds a Ph.D. in plant molecular genetics from Aarhus University, Denmark. He did his postdoctoral training in Norwich, UK, before working as a professor in bioinformatics at Aarhus University. In 2013 Leif joined CLC bio, just before its acquisition by QIAGEN. Since, he has held various bioinformatics Research & Development positions before joining product management in 2018.